Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalTimes Interest Earned

Kiora Pharmaceuticals (KPRX) EBT Margin (2016 - 2024)

Kiora Pharmaceuticals' EBT Margin history spans 9 years, with the latest figure at 84.08% for Q1 2024.

  • For Q1 2024, EBT Margin changed N/A year-over-year to 84.08%; the TTM value through Dec 2024 reached 35.37%, changed N/A, while the annual FY2024 figure was 35.37%, N/A changed from the prior year.
  • EBT Margin reached 84.08% in Q1 2024 per KPRX's latest filing, down from 395301.17% in the prior quarter.
  • In the past five years, EBT Margin ranged from a high of 395301.17% in Q3 2022 to a low of 83119.97% in Q1 2021.
  • Average EBT Margin over 4 years is 128715.79%, with a median of 60772.44% recorded in 2021.
  • The largest YoY upside for EBT Margin was 35803194bps in 2021 against a maximum downside of 35803194bps in 2021.
  • A 4-year view of EBT Margin shows it stood at 9731.65% in 2020, then skyrocketed by 3679bps to 348300.29% in 2021, then increased by 13bps to 395301.17% in 2022, then plummeted by -100bps to 84.08% in 2024.
  • Per Business Quant, the three most recent readings for KPRX's EBT Margin are 84.08% (Q1 2024), 395301.17% (Q3 2022), and 348300.29% (Q4 2021).